Sign in

ASCENTAGE PHARMA GROUP INTERNATIONAL

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Total revenue 0.56 0.98 0.22 0.21 0.03 0.01 0.01 0.01 0.01 0.01
Cost of revenue 0.13 0.03 0.03 0.02 0.00 0.00 0.00 0.00
Gross profit 0.43 0.95 0.19 0.19 0.02 0.01 0.01 0.01 0.01 0.01
Total operating expenses + 1.61 1.32 1.06 1.04 0.96 0.67 0.60 0.33 0.14 0.12
Operating income -1.18 -0.37 -0.87 -0.85 -0.87 -0.66 -0.58 -0.35 -0.13 -0.11
Non-operating income (net) -0.02 -0.03 -0.06 -0.04 0.04 -0.01 -0.90 -0.01 0.01 0.01
Income before tax -1.20 -0.40 -0.93 -0.89 -0.83 -0.68 -1.48 -0.36 -0.12 -0.11
Income tax expense 0.01 0.01 -0.01 0.00 -0.05 0.00 0.00 0.00 0.00
Net income -1.21 -0.41 -0.93 -0.88 -0.78 -0.68 -1.48 -0.35 -0.12 -0.11
Show Quarterly Income Statement
Mar-26 Dec-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Dec-22 Jun-22 Dec-21 Jun-21 Dec-20 Jun-20 Dec-19 Jun-19 Dec-18 Jun-18 Mar-18 Dec-17 Jun-17 Mar-17 Dec-16 Jun-16
Total revenue 0.33 0.33 0.23 0.16 0.16 0.08 0.82 0.41 0.08 0.04 0.14 0.10 0.10 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00
Cost of revenue 0.07 0.07 0.02 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.02 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Gross profit 0.27 0.27 0.21 0.14 0.14 0.07 0.81 0.40 0.07 0.03 0.12 0.09 0.09 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00
Total operating expenses + 0.91 0.91 0.77 0.71 0.71 0.35 0.62 0.31 0.60 0.30 0.47 0.52 0.52 0.45 0.45 0.34 0.34 0.30 0.30 0.22 0.01 0.01 0.13 0.00 0.00 0.06 0.06
Operating income -0.64 -0.64 -0.55 -0.57 -0.57 -0.28 0.19 0.09 -0.53 -0.27 -0.34 -0.42 -0.42 -0.43 -0.43 -0.33 -0.33 -0.29 -0.29 -0.34 -0.01 -0.01 -0.13 0.00 0.00 -0.06 -0.06
Non-operating income (net) 0.00 0.00 -0.03 0.01 0.01 0.00 -0.03 -0.01 0.00 0.00 -0.06 -0.02 -0.02 0.02 0.06 -0.01 -0.01 -0.45 -0.45 -0.02 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Income before tax -0.64 -0.64 -0.59 -0.56 -0.56 -0.28 0.16 0.08 -0.53 -0.27 -0.40 -0.44 -0.44 -0.42 -0.37 -0.34 -0.34 -0.74 -0.74 -0.36 0.00 0.00 -0.12 0.00 0.00 -0.05 -0.05
Income tax expense 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 -0.01 0.00 0.00 0.00 0.00 -0.02 -0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income -0.64 -0.64 -0.59 -0.57 -0.57 -0.28 0.16 0.08 -0.52 -0.26 -0.40 -0.44 -0.44 -0.39 -0.39 -0.34 -0.34 -0.74 -0.74 -0.34 0.00 0.00 -0.11 0.00 0.00 -0.05 -0.05
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Total cash and short-term investments + 2.47 1.24 1.07 1.49 1.71 1.02 0.88 0.97 0.40 0.45
Accounts receivable, net 0.25 0.10 0.16 0.06 0.05 0.00 0.00 0.01 0.01 0.01
Inventories 0.03 0.01 0.02 0.01 0.00 0.00
Other current assets 0.19 0.13 0.10 0.09 0.12 0.06 0.03 0.01 0.01 0.00
Total current assets 2.95 1.47 1.34 1.64 1.89 1.08 0.91 0.99 0.41 0.46
Total non-current assets + 1.02 1.14 1.16 1.19 1.05 0.65 0.30 0.24 0.17 0.13
Total assets 3.97 2.62 2.50 2.83 2.94 1.73 1.21 1.23 0.58 0.59
Total current liabilities + 1.64 1.17 0.93 0.88 0.36 0.28 0.20 0.11 0.08 0.08
Total non-current liabilities + 0.99 1.18 1.50 1.54 1.34 0.61 0.11 2.14 0.63 0.53
Total liabilities 2.63 2.34 2.43 2.42 1.71 0.88 0.31 2.24 0.71 0.61
Total stockholders' equity + 1.33 0.26 0.06 0.41 1.23 0.85 0.89 -1.01 -0.13 -0.01
Common shares outstanding 89 76 18 16 16 13 13 13 13 13
Show Quarterly Balance Sheet
Mar-26 Dec-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Dec-22 Jun-22 Dec-21 Jun-21 Dec-20 Jun-20 Dec-19 Jun-19 Dec-18 Jun-18 Mar-18 Dec-17 Jun-17 Mar-17 Dec-16 Jun-16
Total cash and short-term investments + 2.47 2.47 1.66 1.24 1.24 1.27 1.10 1.10 1.07 1.10 1.58 1.48 1.70 1.71 1.53 1.02 0.65 0.88 0.79 0.97 0.33 0.05 0.40 0.43 0.00 0.00 0.00
Accounts receivable, net 0.25 0.25 0.08 0.10 0.10 0.08 0.85 0.74 0.16 0.15 0.17 0.06 0.16 0.05 0.07 0.00 0.03 0.00 0.00 0.01 0.03 0.01 0.01 0.01
Inventories 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.00
Other current assets 0.19 0.19 0.16 0.13 0.13 0.12 0.11 0.10 0.08 0.09 0.12 0.06 0.03 0.03 0.01 0.01 0.00 0.01 0.01
Total current assets 2.95 2.95 1.91 1.47 1.47 1.47 1.96 1.96 1.34 1.34 1.76 1.64 1.87 1.89 1.60 1.08 0.67 0.91 0.83 0.99 0.38 0.06 0.41 0.44
Total non-current assets + 1.02 1.02 1.14 1.14 1.14 1.14 1.14 1.14 1.16 1.16 1.16 1.19 1.17 1.05 0.81 0.65 0.43 0.30 0.24 0.24 0.19 0.03 0.17 0.15
Total assets 3.97 3.97 3.05 2.62 2.62 2.62 3.11 3.11 2.50 2.50 2.92 2.83 3.03 2.94 2.41 1.73 1.11 1.21 1.07 1.23 0.57 0.09 0.58 0.59
Total current liabilities + 1.64 1.64 1.24 1.17 1.17 1.17 1.07 1.07 0.93 0.93 0.64 0.88 0.61 0.36 0.19 0.28 0.14 0.20 0.18 0.11 0.15 0.02 0.08 0.08
Total non-current liabilities + 0.99 0.99 1.13 1.18 1.18 1.18 1.27 1.27 1.50 1.50 1.68 1.54 1.55 1.34 0.76 0.61 0.36 0.11 2.52 2.14 0.63 0.09 0.63 0.58
Total liabilities 2.63 2.63 2.37 2.34 2.34 2.34 2.33 2.33 2.43 2.43 2.32 2.42 2.16 1.71 0.96 0.88 0.49 0.31 2.70 2.24 0.77 0.12 0.71 0.66
Total stockholders' equity + 1.33 1.33 0.67 0.26 0.26 0.26 0.77 0.77 0.06 0.06 0.59 0.41 0.88 1.23 1.45 0.85 0.61 0.89 -1.62 -1.01 -0.22 -0.03 -0.13 -0.07
Common shares outstanding 93 93 85 78 78 312 74 296 73 290 18 16 16 16 16 13 13 13 13 13 12 49 13 12 49 13 13
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Operating cash flow + -1.17 -0.11 -0.73 -0.65 -0.60 -0.61 -0.46 -0.24 -0.11 -0.05
Cash flow from investing + -1.00 -0.36 0.02 -0.38 -0.47 -0.11 -0.20 0.29 -0.23 -0.16
Cash flow from financing + 2.54 0.31 0.37 0.62 1.78 1.04 0.44 0.86 0.06 0.46
Change in cash 0.37 -0.16 -0.34 -0.42 0.71 0.32 -0.22 0.92 -0.28 0.25
Show Quarterly Cash Flow
Mar-26 Dec-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Dec-22 Jun-22 Dec-21 Jun-21 Dec-20 Jun-20 Dec-19 Jun-19 Dec-18 Jun-18 Mar-18 Dec-17 Jun-17 Mar-17 Dec-16 Jun-16
Operating cash flow + -0.78 -0.78 -0.45 0.22 0.24 0.12 -0.39 -0.18 -0.36 -0.18 -0.44 -0.34 -0.37 -0.22 -0.36 -0.31 -0.30 -0.22 -0.22 -0.12 -0.12 -0.06 -0.10 -0.02 0.00 -0.02 -0.02
Cash flow from investing + -0.30 -0.30 -0.70 -0.24 -0.23 -0.12 -0.13 -0.07 0.09 0.04 -0.06 -0.23 -0.15 0.53 -1.00 0.09 -0.21 -0.16 -0.04 0.26 0.25 0.03 -0.20 -0.19 -0.03 -0.08 -0.08
Cash flow from financing + 1.60 1.60 0.96 -0.05 -0.08 -0.04 0.43 0.20 -0.07 -0.04 0.52 0.16 0.48 0.71 1.08 0.83 0.20 0.38 0.22 0.79 0.07 0.03 0.05 0.04 0.01 0.22 0.22
Change in cash 0.52 0.52 -0.18 -0.07 -0.07 -0.03 -0.09 -0.04 -0.34 -0.18 0.02 -0.40 -0.03 1.02 -0.28 0.60 -0.31 0.00 -0.04 0.94 0.20 0.00 -0.26 -0.16 -0.02 0.12 0.12
4 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Change In Inventory

1Y 2Y 5Y Max
8 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Stock Based Compensation

1Y 2Y 5Y Max
8 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Net Income

1Y 2Y 5Y Max
8 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
8 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Cashflow From Financing

1Y 2Y 5Y Max
8 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Cashflow From Investment

1Y 2Y 5Y Max
8 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Capital Expenditures

1Y 2Y 5Y Max
8 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
8 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Operating Cashflow

1Y 2Y 5Y Max
8 days ago

ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) - Net Income

1Y 2Y 5Y Max
8 days ago